- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
HP adds free Albunex on Sonos 5500
Hewlett-Packard of Andover, MA, has struck a deal with St. Louis-based Mallinckrodt that will allow the cardiovascular ultrasound market leader to include a complimentary Albunex ultrasound contrast media starter kit along with its premium Sonos 5500
Hewlett-Packard of Andover, MA, has struck a deal with St. Louis-based Mallinckrodt that will allow the cardiovascular ultrasound market leader to include a complimentary Albunex ultrasound contrast media starter kit along with its premium Sonos 5500 ultrasound scanner. The arrangement builds on the harmonic imaging package offered for Sonos 5500, which was launched earlier this month (SCAN 6/11/97).
Under the arrangement, announced at the American Society of Echocardiography meeting, Mallinckrodt will provide the Albunex starter kit to customers who order Sonos 5500 with its harmonic imaging package, or upgrade an existing system to harmonic imaging. This offer will extend at least through the end of 1997, according to Mallinckrodt, which markets and distributes Albunex. Albunex, which is the only ultrasound contrast agent available in the U.S., is manufactured by Molecular Biosystems of San Diego.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
